131 related articles for article (PubMed ID: 34780932)
1. Tamoxifen for the Treatment of Etonogestrel Implant-Associated Bleeding in an Adolescent Gynecology Practice.
Friedman JC; Buyers E; Laurin J; Hampanda K; Alaniz VI
J Pediatr Adolesc Gynecol; 2022 Jun; 35(3):341-345. PubMed ID: 34780932
[TBL] [Abstract][Full Text] [Related]
2. Twelve-month Continuation of the Etonogestrel Implant in Adolescents With Polycystic Ovary Syndrome.
Buyers E; Sass AE; Severn CD; Pyle L; Cree-Green M
J Pediatr Adolesc Gynecol; 2021 Feb; 34(1):33-39. PubMed ID: 32919086
[TBL] [Abstract][Full Text] [Related]
3. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S;
Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users: A Randomized Controlled Trial.
Edelman AB; Kaneshiro B; Simmons KB; Hauschildt JL; Bond K; Boniface ER; Jensen JT
Obstet Gynecol; 2020 Aug; 136(2):323-332. PubMed ID: 32649493
[TBL] [Abstract][Full Text] [Related]
5. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.
Ireland LD; Goyal V; Raker CA; Murray A; Allen RH
Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904
[TBL] [Abstract][Full Text] [Related]
6. Menstrual bleeding patterns in adolescents using etonogestrel (ENG) implant.
Deokar AM; Jackson W; Omar HA
Int J Adolesc Med Health; 2011; 23(1):75-7. PubMed ID: 21721368
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen for the treatment of breakthrough bleeding with the etonogestrel implant: a randomized controlled trial.
Simmons KB; Edelman AB; Fu R; Jensen JT
Contraception; 2017 Feb; 95(2):198-204. PubMed ID: 27725164
[TBL] [Abstract][Full Text] [Related]
8. The Etonogestrel Implant in Adolescents: Factors Associated With Removal for Bothersome Bleeding in the First Year After Insertion.
Green S; Sheeder J; Richards M
J Pediatr Adolesc Gynecol; 2021 Dec; 34(6):825-831. PubMed ID: 34089858
[TBL] [Abstract][Full Text] [Related]
9. Immediate postpartum etonogestrel implant: a contraception option with long-term continuation.
Wilson S; Tennant C; Sammel MD; Schreiber C
Contraception; 2014 Sep; 90(3):259-64. PubMed ID: 24993485
[TBL] [Abstract][Full Text] [Related]
10. Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial.
Vieira CS; de Nadai MN; de Melo Pereira do Carmo LS; Braga GC; Infante BF; Stifani BM; Ferriani RA; Quintana SM
Contraception; 2019 Oct; 100(4):258-263. PubMed ID: 31145885
[TBL] [Abstract][Full Text] [Related]
11. Amenorrhea in adolescents using the etonogestrel contraceptive implant.
Tsevat D; Mercier R; Bernheimer C; Lin S; Schwartz B
Contraception; 2024 May; 133():110413. PubMed ID: 38401772
[TBL] [Abstract][Full Text] [Related]
12. Twelve-month discontinuation of etonogestrel implant in an outpatient pediatric setting.
Berlan E; Mizraji K; Bonny AE
Contraception; 2016 Jul; 94(1):81-6. PubMed ID: 26948183
[TBL] [Abstract][Full Text] [Related]
13. Assessing Weight Status in Adolescent and Young Adult Users of the Etonogestrel Contraceptive Implant.
Romano ME; Braun-Courville DK
J Pediatr Adolesc Gynecol; 2019 Aug; 32(4):409-414. PubMed ID: 30928532
[TBL] [Abstract][Full Text] [Related]
14. Relationship Between Etonogestrel Concentrations and Bleeding Patterns in Contraceptive Implant Users.
Lazorwitz A; Aquilante CL; Dindinger E; Harrison M; Sheeder J; Teal S
Obstet Gynecol; 2019 Oct; 134(4):807-813. PubMed ID: 31503152
[TBL] [Abstract][Full Text] [Related]
15. A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant.
Apter D; Briggs P; Tuppurainen M; Grunert J; Lukkari-Lax E; Rybowski S; Gemzell-Danielsson K
Fertil Steril; 2016 Jul; 106(1):151-157.e5. PubMed ID: 27016644
[TBL] [Abstract][Full Text] [Related]
16. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.
Ali M; Akin A; Bahamondes L; Brache V; Habib N; Landoulsi S; Hubacher D;
Hum Reprod; 2016 Nov; 31(11):2491-2498. PubMed ID: 27671673
[TBL] [Abstract][Full Text] [Related]
17. Bleeding related to etonogestrel subdermal implant in a US population.
Casey PM; Long ME; Marnach ML; Bury JE
Contraception; 2011 May; 83(5):426-30. PubMed ID: 21477684
[TBL] [Abstract][Full Text] [Related]
18. Can initial vaginal bleeding patterns in etonogestrel implant users predict subsequent bleeding in the first 2 years of use?
Mansour D; Fraser IS; Edelman A; Vieira CS; Kaunitz AM; Korver T; Pong A; Lin J; Shah AK; Fox M; Rekers H; Creinin MD
Contraception; 2019 Oct; 100(4):264-268. PubMed ID: 31176688
[TBL] [Abstract][Full Text] [Related]
19. ENG-releasing subdermal implants in postpartum teenagers - an open-label trial study protocol.
Barbieri MM; Juliato CRT; Bahamondes L; Surita FG
Reprod Health; 2020 Jun; 17(1):100. PubMed ID: 32576199
[TBL] [Abstract][Full Text] [Related]
20. Early removal of etonogestrel subcutaneous contraceptive implant at a community health centre in Pretoria.
Moeti DMP; Govender I; Bongongo T
S Afr Fam Pract (2004); 2022 Jul; 64(1):e1-e6. PubMed ID: 35924618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]